Noll L. Campbell
 |
Contact Information Email: campbenl@purdue.edu Phone: 317-630-2214 Fax: 317-630-8776 Homepage: Homepage |
Associate Professor of Pharmacy Practice PubMed Listing  Google Scholar Listing  View Vita
|
Education
PharmD Butler University Pharmacy 2002
Research Interests
adverse cognitive effects of medications in older adults, geriatric pharmacotherapy
Teaching Interests
geriatric pharmacotherapy, dementia
Grants
2019 - National Institute on Aging
2019 - National Institute on Aging
2018 - Health Resources and Service Administration
Selected Publications
Campbell NL, Holden RJ, Tang Q, Boustani MA, Teal E, Hillstrom J, Tu W, Clark DO, Callahan CM. Multi-component Behavioral Intervention To Reduce Exposure To Anticholinergics In Primary Care Older Adults. J Amer Geriatr Soc 2021; 2021 Mar 26. Doi: 10.1111/jgs.17121. Online Ahead Of Print..
Campbell NL, Holden R, Boustani MA. Preventing Alzheimer Disease By Deprescribing Anticholinergic Medications. JAMA Intern Med 2019 Jun; 179(8):1084-1093. Doi: 10.1001/jamainternmed.2019.0676. PMID: 31233087.
Campbell NL, Perkins AJ, Khan BA, Gao S, Farber MO, Boustani MA. Deprescribing In The Pharmacologic Management Of Delirium (de-PMD): A Randomized Trial In The Intensive Care Unit. J Am Geriatr Soc 2019 Apr;67(4):695-702. Doi:10.1111/jgs.15751.
Campbell NL, Lane KA, Gao S, Boustani M, Unverzagt F. Anticholinergics Increase Transition From Normal Cognition To Mild Cognitive Impairment In Community-dwelling Older Adults. Pharmacotherapy 2018 May;38(5):511-519. Doi: 10.1002/phar.2106. Epub 2018 Apr 25. PMID: 29600808. Https://doi.org/10.1002/phar.2106.
Campbell NL, Perkins AP, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA. Adherence And Tolerability Of Alzheimers Disease Medications: A Pragmatic Randomized Trial. J Am Geriatri Soc 2017;65(7):1497-1504.